Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Lang

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Anticancer Research|April 30, 2016
Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A RegimeStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Radiation Oncology (London, England)|July 26, 2014
Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacyStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2013
Clinical application of flattening filter free beams for extracranial stereotactic radiotherapyStephanie Lang, Binaya Shrestha, Shaun Graydon, et al.
Medical Physics|March 3, 2012
Pretreatment quality assurance of flattening filter free beams on 224 patients for intensity modulated plans: a multicentric studyStephanie Lang, Giacomo Reggiori, Josep Puxeu Vaquee, et al.
Cornea|July 24, 2024
Interpretable Machine Learning-Based Risk Score for Predicting 10-Year Corneal Graft Survival After Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty in Asian EyesClarissa Ng Yin Ling, Feng He, Stephanie Lang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2011
Effect of high dose per pulse flattening filter-free beams on cancer cell survivalInes Lohse, Stephanie Lang, Jan Hrbacek, et al.
Radiation Oncology (London, England)|November 12, 2014
PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markersChristoph Oehler, Stephanie Lang, Peter Dimmerling, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2012
The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localized prostate cancerDaniel R Zwahlen, Stephanie Lang, Jan Hrbacek, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 10, 2019
Methotrexate as an Adjuvant in Severe Thyroid Eye Disease: Does It Really Work as a Steroid-Sparing Agent?Kai-Ling Yong, Chiaw-Ling Chng, Nicole Ming Sie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2015
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinomaMarta Nesteruk, Stephanie Lang, Patrick Veit-Haibach, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Anticancer Research|April 30, 2016
Hypofractionated Radiotherapy for Breast Cancer Including Risk-adapted Boost: Update on Tolerance and Efficacy of an Accelerated START A RegimeStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Radiation Oncology (London, England)|July 26, 2014
Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacyStefan Janssen, Christoph Glanzmann, Stephanie Lang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2013
Clinical application of flattening filter free beams for extracranial stereotactic radiotherapyStephanie Lang, Binaya Shrestha, Shaun Graydon, et al.
Medical Physics|March 3, 2012
Pretreatment quality assurance of flattening filter free beams on 224 patients for intensity modulated plans: a multicentric studyStephanie Lang, Giacomo Reggiori, Josep Puxeu Vaquee, et al.
Cornea|July 24, 2024
Interpretable Machine Learning-Based Risk Score for Predicting 10-Year Corneal Graft Survival After Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty in Asian EyesClarissa Ng Yin Ling, Feng He, Stephanie Lang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 8, 2011
Effect of high dose per pulse flattening filter-free beams on cancer cell survivalInes Lohse, Stephanie Lang, Jan Hrbacek, et al.
Radiation Oncology (London, England)|November 12, 2014
PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markersChristoph Oehler, Stephanie Lang, Peter Dimmerling, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2012
The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localized prostate cancerDaniel R Zwahlen, Stephanie Lang, Jan Hrbacek, et al.
Ophthalmic Plastic and Reconstructive Surgery|January 10, 2019
Methotrexate as an Adjuvant in Severe Thyroid Eye Disease: Does It Really Work as a Steroid-Sparing Agent?Kai-Ling Yong, Chiaw-Ling Chng, Nicole Ming Sie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2015
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinomaMarta Nesteruk, Stephanie Lang, Patrick Veit-Haibach, et al.
Pageof 4